|
PART I CARCINOGENESIS AND CANCER GENETICS |
|
|
|
1 Cancer: A Genetic Disorder |
|
|
3 | (16) |
|
|
|
2 Oncogenes and Signal Transduction |
|
|
19 | (16) |
|
|
|
|
35 | (12) |
|
|
|
4 DNA Repair Pathways and Human Cancer |
|
|
47 | (20) |
|
|
|
67 | (12) |
|
|
6 Infectious Agents and Cancer |
|
|
79 | (24) |
|
|
7 Environmental Carcinogenesis |
|
|
103 | (26) |
|
|
|
8 Animal Models: Flies, Fish, and Yeast |
|
|
129 | (16) |
|
|
|
9 Genetic Mouse Models of Cancer |
|
|
145 | (12) |
|
|
|
|
|
10 Cancer Stem Cells and the Microenvironment |
|
|
157 | (8) |
|
|
|
|
11 Regulation of the Cell Cycle |
|
|
165 | (14) |
|
|
|
|
|
179 | (12) |
|
|
|
13 The Metabolism of Cell Growth and Proliferation |
|
|
191 | (18) |
|
|
|
14 Apoptosis, Necrosis, and Autophagy |
|
|
209 | (20) |
|
|
|
|
|
229 | (10) |
|
|
|
16 The Role of the Microenvironment in Tumor Initiation, Progression, and Metastasis |
|
|
239 | (18) |
|
|
|
|
|
257 | (12) |
|
|
|
18 Invasion and Metastasis |
|
|
269 | (16) |
|
|
|
|
|
19 Inflammation and Cancer |
|
|
285 | (12) |
|
|
|
20 Cancer Systems Biology: The Future |
|
|
297 | (20) |
|
|
PART III MOLECULAR PATHOLOGY AND DIAGNOSTICS |
|
|
|
21 Biomarkers for Assessing Risk of Cancer |
|
|
317 | (14) |
|
|
|
22 Protein Biomarkers for Detecting Cancer: Molecular Screening |
|
|
331 | (16) |
|
|
|
23 The Technology of Analyzing Nucleic Acids in Cancer |
|
|
347 | (10) |
|
|
24 Understanding and Using Information about Cancer Genomes |
|
|
357 | (12) |
|
|
|
|
25 High-Content Analysis with Cellular and Tissue Systems Biology: A Bridge between Cancer Cell Biology and Tissue-Based Diagnostics |
|
|
369 | (26) |
|
|
|
|
|
|
|
|
PART IV MOLECULAR PATHOGENESIS AND THERAPEUTIC TARGETS FOR SPECIFIC CANCERS |
|
|
|
26 Molecular Genetics of Acute Lymphoblastic Leukemia |
|
|
395 | (12) |
|
|
|
|
|
27 Molecular Biology of Childhood Neoplasms |
|
|
407 | (14) |
|
|
28 Biology of Adult Myelocytic Leukemia and Myelodysplasia |
|
|
421 | (12) |
|
|
|
|
|
433 | (22) |
|
|
|
|
|
|
|
|
|
455 | (12) |
|
|
|
31 Molecular Mechanisms of Esophageal Cancer |
|
|
467 | (8) |
|
|
|
|
32 Molecular Basis of Lung Cancer |
|
|
475 | (16) |
|
|
|
|
33 The Molecular Pathogenesis of Head and Neck Cancer |
|
|
491 | (8) |
|
|
|
34 Colon and Rectal Cancer |
|
|
499 | (16) |
|
|
35 Molecular Pathogenesis of Pancreatic Adenocarcinoma |
|
|
515 | (8) |
|
|
|
36 The Molecular Biology of Breast Cancer |
|
|
523 | (8) |
|
|
|
|
37 Molecular Pathogenesis of Ovarian Cancer |
|
|
531 | (18) |
|
|
|
|
38 Molecular Basis of Prostate Cancer |
|
|
549 | (12) |
|
|
|
|
|
|
39 Molecular Abnormalities in Kidney Cancer |
|
|
561 | (12) |
|
|
|
|
40 The Biology of Primary Brain Tumors |
|
|
573 | (8) |
|
|
|
41 Epithelial Skin Cancer |
|
|
581 | (10) |
|
|
|
42 Molecular Basis for Treating Cutaneous Molecular |
|
|
591 | (10) |
|
|
|
601 | (8) |
|
|
|
609 | (12) |
|
|
Christopher D. M. Fletcher |
|
|
PART V MOLECULAR BASIS OF CANCER THERAPY |
|
|
|
45 From Bench to Bedside with Targeted Therapies |
|
|
621 | (14) |
|
|
|
635 | (16) |
|
|
|
|
47 Natural and Acquired Resistance to Cancer Therapies |
|
|
651 | (10) |
|
|
|
661 | (16) |
|
|
|
|
|
|
|
677 | (6) |
|
|
|
50 Monoclonal Antibodies for the Treatment of Cancer |
|
|
683 | (12) |
|
|
|
51 Cancer and the Cellular Immune Response |
|
|
695 | (14) |
|
|
|
|
52 Cancer Immunotherapy with Vaccines and Checkpoint Blockade |
|
|
709 | (30) |
|
|
|
739 | (14) |
|
|
54 Gene Therapy and Oncolytic Viruses |
|
|
753 | (16) |
|
|
|
|
55 RNA as a Therapeutic Molecule |
|
|
769 | (10) |
|
|
|
56 Heat Shock Protein 90 and the Proteasome: Housekeeping Proteins That Are Also Molecular Targets for Cancer Therapy |
|
|
779 | (10) |
|
|
|
57 Hematopoietic Growth Factors and Cytokines |
|
|
789 | (20) |
|
|
|
|
58 Cancer Chemoprevention |
|
|
809 | (16) |
|
|
|
|
825 | |
|